Clinical Research Evaluates Folinic Acid for Brain Development Support in Children - FolinicActive Kids Delivers Ingredient at Studied Dose

AUSTIN, TX - March 19, 2026 - Published research in Molecular Psychiatry evaluating folinic acid supplementation in children found that participants receiving folinic acid showed meaningfully greater verbal communication improvements than those receiving placebo, according to Triquetra Health. FolinicActive Kids, now available on Amazon, contains pharmaceutical-grade folinic acid at age-appropriate doses designed to help support their growing brain and healthy development in children ages 1-18.* The formula provides multi-pathway folate flexibility alongside the complete B-vitamin support team - translating published pediatric research into an accessible daily supplement for kids who need a gentler approach.*

Families of children with autism spectrum characteristics, MTHFR variants, or developmental support needs increasingly seek evidence-based active folate options formulated specifically for children. Published research suggests folate receptor autoantibodies may be present in a meaningful portion of children with autism spectrum characteristics - a mechanism folinic acid, which enters folate metabolism via the reduced folate carrier pathway, is specifically positioned to address.* Yet until FolinicActive Kids, no USDA Organic for growing bodies folinic acid formula existed with age-tiered dosing and the complete B-vitamin support team designed for children across the 1-18 age range.

The double-blind, placebo-controlled trial by Frye et al. (2018), published in Molecular Psychiatry, enrolled 48 children (mean age 7.3 years) and studied folinic acid at 2 mg/kg/day for 12 weeks. The folinic acid group demonstrated a 65% response rate for verbal communication improvements versus 24% in the placebo group (Cohen's d = 0.70; P = 0.003; number needed to treat = 2.4). The folinic acid group also experienced approximately 30% fewer adverse events than the placebo group, with zero treatment discontinuations in the active arm - a tolerance profile that may help support their growing brain in sensitive children who need a gentler approach.* An independent replication by Panda et al. (2024), published in the European Journal of Pediatrics, studied 80 children over 24 weeks and confirmed significant developmental assessment score improvements, with enhanced observations in the folate receptor autoantibody-positive subgroup. FolinicActive Kids is available at amazon.com/dp/B0G4S6KXDX.

These published findings reflect multi-pathway folate flexibility - the property of folinic acid that allows it to enter folate metabolism at the upstream THF hub and support DNA synthesis, purine biosynthesis, and the methylation cycle from a single substrate, based on developing systems' own metabolic priorities.* This metabolic breadth distinguishes folinic acid from methylfolate, which enters cells with a single metabolic destination. The complete B-vitamin support team amplifies this foundation: the vitamin B-12 tri-blend supports both cytoplasmic methylation and mitochondrial energy; active P-5-P supports SHMT enzyme function to help generate the methyleneTHF intermediates that feed downstream pathways; and R-5-P provides the FAD cofactor that MTHFR requires to process those intermediates into 5-methylTHF for the methylation cycle.*

"The Frye 2018 research is notable for two findings: the meaningful difference in verbal communication response rates between folinic acid and placebo, and the tolerance data showing fewer adverse events in the active group with zero discontinuations," said [Scientific Advisor Name], PhD, Scientific Advisor to Triquetra Health. "For families seeking a way to help support their growing brain in children who need a gentler approach, this clinical foundation - paired with the complete B-vitamin support team including the R-5-P cofactor most pediatric formulas omit - represents the most complete evidence-based pediatric folate formula currently available.*"

FolinicActive Kids delivers folinic acid at age-appropriate doses in a USDA Organic for growing bodies formula (organic vegetable glycerin base, organic citric acid, organic natural flavor) with berry flavor kids actually like for consistent daily compliance.* Age-tiered dosing (ages 1-3: 5 drops; ages 4-13: 10 drops; ages 14-18: 15 drops) provides 213-638 mcg DFE per serving. Manufactured in FDA-registered, cGMP-certified facilities; third-party tested for heavy metals. For complete clinical research summaries, visit triquetrahealth.com/products/folinicactive-kids.

FolinicActive Kids is available on Amazon at https://www.amazon.com/dp/B0G4S6KXDX. For published research citations supporting multi-pathway folate flexibility and calm, happy moods in growing children, visit triquetrahealth.com/products/folinicactive-kids.*

About Triquetra Health

Triquetra Health develops evidence-based nutritional supplements for consumers who demand clinical validation and clean-label quality. As America's #1 folate brand, the company offers complete solutions across the full spectrum of folate needs - including both kids methylfolate and folinic acid formulations - because every child is different. All Triquetra Health products are manufactured in FDA-registered, cGMP-certified facilities with comprehensive third-party testing for purity, potency, and heavy metals. For more information, visit triquetrahealth.com.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Media Contact:

Brittany Blevins

VP of Marketing

Triquetra Health

support@triquetrahealth.com

triquetrahealth.com

Media Contact
Company Name: Triquetra Health
Contact Person: Brittany Belew
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=clinical-research-evaluates-folinic-acid-for-brain-development-support-in-children-folinicactive-kids-delivers-ingredient-at-studied-dose]
Country: United States
Website: https://triquetrahealth.com/products/folinicactive-kids-drops?_pos=1&_sid=037c2c3e7&_ss=r

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.